Related Experiment Videos
Mood alterations in patients treated with chlorambucil
Sean T Hehn1, Robert T Dorr, Thomas P Miller
1Arizona Cancer Center, The University of Arizona, Tucson, USA.
Clinical Lymphoma
|January 13, 2004
Summary
High-dose chlorambucil can cause seizures, but new findings show it also causes mood alterations like anxiety and depression in lymphoma patients. These effects resolve after treatment stops.
Area of Science:
- Oncology
- Pharmacology
- Neuroscience
Background:
- Chlorambucil, an alkylating agent, is a standard chemotherapy for various cancers.
- Known toxicities include myelosuppression and rare central nervous system effects like seizures at high doses.
Purpose of the Study:
- To report previously undocumented mood alterations associated with intermittent oral chlorambucil therapy.
- To expand the known toxicity profile of chlorambucil.
Main Methods:
- Observational study of lymphoma patients receiving intermittent pulsed oral chlorambucil (10-12 mg/m2/day for 5 days).
- Monitoring and documentation of patient-reported adverse effects during and after therapy.
Main Results:
- Patients experienced significant mood alterations, including anxiety, restlessness, irritability, depression, and sleep disturbances.
- These mood-related side effects were temporary and resolved immediately upon completion of the chlorambucil dosing regimen.
Conclusions:
- Mood alterations represent a novel toxicity of chlorambucil therapy.
- These effects can occur with standard oral dosing schedules and should be considered in patient management.